Pešić, Milica

Type

Date issued

335 2000 - 2027

Mp-cat.

Date issued - custom

Year from:

Year to:

Results 121-140 of 335 Results/Page

Issue Date	Title	Author(s)	Type	Мp-cat.
2021	New therapeutic strategy for overcoming multidrug resistance in cancer cells with pyrazolo[3,4‐d]pyrimidine tyrosine kinase inhibitors	Podolski-Renić, Ana ; Dinić, Jelena ; Stanković, Tijana; Tsakovska, Ivanka; Pajeva, Ilza; Tuccinardi, Tiziano; Botta, Lorenzo; Schenone, Silvia; Pešić, Milica	Article	21M21
2021	Pyrazolo[3,4-d]pyrimidine derivatives, Si306 and pro-Si306, induce oxidative stress and cell death in patient-derived glioblastoma cells	Kostić, Ana ; Podolski-Renić, Ana ; Jovanović Stojanov, Sofija ; Nešović, Marija ; Dragoj, Miodrag ; Jovanović, Mirna ; Nikolić, Igor ; Tasić, Goran ; Schenone, Silvia; Pešić, Milica ; Dinić, Jelena ;	Conference Paper	Mp. category will be shown later
2021	Overcoming paclitaxel-induced multidrug resistance in glioblastoma cells by using a combination of metformin and bafilomycin A1	Alves, Sara; Natalino, Mariana; Dinić, Jelena ; Pešić, Milica ; Vasconcelos, Helena	Conference Paper	Mp. category will be shown later
2020	Royleanone Derivatives From Plectranthus spp. as a Novel Class of P-Glycoprotein Inhibitors	Garcia, Catarina; Isca, Vera; Pereira, Filipe; Monteiro, Carlos; Ntungwe, Epole; Sousa, Francisco; Dinić, Jelena ; Holmstedt, Suvi; Roberto, Amílcar; Díaz-Lanza, Ana; Reis, Catarina; Pešić, Milica ; Candeias, Nuno; Ferreira, Ricardo; Duarte, Noélia; Afonso, Carlos; Rijo, Patrícia;	Article	21aM21a
2020	Novel class of P-glycoprotein inhibitors from Plectranthus spp.	Vera M. S. Isca; Jaime A. S. Coelho; Carlos M. Monteiro; Epole Ntungwe; Eva María Dominguez-Martín; Dinić, Jelena B. ; Ana María Díaz-Lanza; Nuno R. Candeias; Carlos A. M. Afonso; Milica Pesic ; Patrícia Rijo;	Conference Paper	Mp. category will be shown later
2020	Natural Products: Optimizing Cancer Treatment through Modulation of Redox Balance	Rijo, Patrícia; Pešić, Milica ; Fernandes, Ana S.; Santos, Cláudia N.	Article	21M21
2020	Presentation of STSM: Investigation of inhibitory properties of Michael acceptors on thioredoxin reductase 1 inhibition in vitro	Jovanović, Mirna ; Podolski-Renić, Ana ; Žalubovskis, Raivis; Pešić, Milica	Conference Paper	Mp. category will be shown later
2020	In silico study to elucidate possible interactions of Hsp90 inhibitors with P-gp	Ilza Pajeva; Ivanka Tsakovska; Petko Alov; Tania Pencheva; Iglika Lessigiarska; Dinić, Jelena B. ; Podolski Renić, Ana M. ; Jovanović, Mirna ; Loana Musso; Sabrina Dallavalle; Pešić, Milica S. ;	Conference Paper	Mp. category will be shown later
2020	Biomedicine: biodiversity’s panacea? Context of commodification	Johnson, Mari-Vaughn V.; Shrestha, Uttam Babu; Neergheen, Vidushi S.; Kagansky, Alexander; Pešić, Milica ; Malone, John H.	Book parts	Mp. category will be shown later
2020	Molecular Docking Studies of Royleanone Diterpenoids from Plectranthus spp. as P-Glycoprotein Inhibitors	Isca, Vera M. S.; Ferreira, Ricardo J.; Garcia, Catarina; Monteiro, Carlos M.; Dinić, Jelena ; Holmstedt, Suvi; André, Vânia; Pešić, Milica ; Dos Santos, Daniel J. V. A.; Candeias, Nuno R.; Afonso, Carlos A. M.; Rijo, Patrícia;	Article	21aM21a
2020	Grape (Vitis vinifera L.): health benefits and effects of growing conditions on quality parameters	Topalović, Ana; Knežević, Mirko; Bajagić, Balša; Ivanović, Ljubica; Milašević, Ivana; Đurović, Dijana; Mugoša, Boban; Podolski-Renić, Ana ; Pešić, Milica	Book parts	Mp. category will be shown later
2020	Cytotoxic royleanones from Plectranthus madagascariensis as agents to overcome multidrug resistant in cancer	Isca, V.M.S.; Ferreira, R.J.; Santos, D.; Saraiva, L.; Afonso, C.A.M.; Pešić, Milica S. ; Rijo, P.	Conference Paper	Mp. category will be shown later
2020	Plectranthus mutabilis Codd as a source of Anti-MDR Diterpenoids	Ntungwea, E.N.; Isca, V.; Tavares, J.; Vágvölgyi, M.; Pešić, Milica S. ; Spengler, G.; Hunyadi, A.; Rijo, P.	Conference Paper	Mp. category will be shown later
2020	Population pharmacokinetic analysis of bisoprolol in type 2 diabetic patients with hypertension	Momčilović, Stefan ; Jovanović, Andriana; Radojković, Danijela ; Nikolić, Valentina N. ; Janković, Slobodan ; Pešić, Milica ; Milovanović, Jasmina R.	Article	22M22
2020	Protoflavone-Chalcone Hybrids Exhibit Enhanced Antitumor Action through Modulating Redox Balance, Depolarizing the Mitochondrial Membrane, and Inhibiting ATR-Dependent Signaling	Latif, Ahmed Dhahir; Jernei, Tamás; Podolski-Renić, Ana ; Kuo, Ching-Ying; Vágvölgyi, Máté; Girst, Gábor; Zupkó, István; Develi, Sedef; Ulukaya, Engin; Wang, Hui-Chun; Pešić, Milica ; Csámpai, Antal; Hunyadi, Attila;	Article	21aM21a
2020	Further exploration of DVD-445 as a lead thioredoxin reductase (TrxR) inhibitor for cancer therapy: Optimization of potency and evaluation of anticancer potential.	Jovanović, Mirna ; Zhukovsky, Daniil; Podolski-Renić, Ana ; Žalubovskis, Raivis; Dar'in, Dmitry; Sharoyko, Vladimir; Tennikova, Tatiana; Pešić, Milica ; Krasavin, Mikhail	Article	21aM21a
2020	Towards policies that capture the expected value of biomolecular diversity for drug discovery, human health, and well-being	Pešić, Milica ; Egamberdieva, Dilfuza; Kolodziejczyk, Bartlomiej; Elsässer, Simon J.; Neergheen, Vidushi S.; Kagansky, Alexander	Article	22M22
2020	Novel TrxR1 Inhibitors Show Potential for Glioma Treatment by Suppressing the Invasion and Sensitizing Glioma Cells to Chemotherapy	Jovanović, Mirna ; Dragoj, Miodrag ; Zhukovsky, Daniil; Dar’in, Dmitry; Krasavin, Mikhail; Pešić, Milica ; Podolski-Renić, Ana	Article	21M21
2020	Validation of long-term 3D glioblastoma cell culture as a novel biomimicking model system for preclinical drug testing	Stanković, Tijana; Dragoj, Miodrag ; Stojkovska, Jasmina ; Dinić, Jelena ; Podolski-Renić, Ana ; Obradović, Bojana ; Pešić, Milica	Conference Paper	Mp. category will be shown later
2020	Investigation of inhibitory properties of Michael acceptors on thioredoxin reductase 1 inhibition in vitro	Jovanović, M.; Podolski Renić, Ana M. ; Žalubovskis, R.; Pešić, Milica S.	Conference Paper	Mp. category will be shown later